利用精油来抑制乙胆酶:一篇文献综述
Solmaz Asnaashari1, Ali Jahanban-Esfahlan1, Ryszard Amarowicz2
1Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Phytotherapy research : PTR
|May 13, 2025
概括
使用植物精油的芳香疗法通过抑制乙胆酶 (AChE) 来治疗阿尔茨海默病 (AD) 是有前途的. 迷香和衣草油由于其关键化学化合物而特别有效.
科学领域:
- 整合和补充医学是整合和补充医学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降.
- 乙胆酶 (AChE) 抑制剂是阿尔茨海默病的主要药理治疗方法,但仍在寻求非药理方法.
- 使用植物精油 (EO) 的芳香疗法正在因其潜在的认知增强和神经保护作用而受到探索.
研究的目的:
- 审查各种植物EO对乙胆酶 (AChE) 活性的抑制作用.
- 为了确定负责ACHE抑制的EO中关键化学成分.
- 评估EO作为管理阿尔茨海默病的非药物战略的潜力.
主要方法:
- 关于研究植物EO对ACHE活动的影响的综合文献综述.
- 对已报告具有ACHE抑制性质的EO的化学成分进行分析.
- 确定与神经保护机制相关的特定化学成分.
主要成果:
- 来自Lamiaceae家族的精油,特别是迷香 (Salvia rosmarinus) 和衣草 (Lavandula officinalis),表现出强大的ACHE抑制作用.
- 确定的主要活性成分包括α-和β-皮,利蒙,林纳醇,1,8-基,卡里奥菲林,基,欧根醇和阿萨龙.
- 这些化合物有助于研究EO的神经保护性质.
结论:
- 特定的植物精油,特别是来自迷香和衣草的精油,显示出抑制ACHE的巨大潜力.
- 已识别的化学成分对于观察到的治疗效果至关重要.
- 芳香疗法为管理阿尔茨海默病和其他神经退行性疾病的认知衰退提供了一个有希望的补充方法.
相关概念视频
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.3K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.2K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K


